Nexalin Secures $15M Equity Line with Alumni Capital and Adds $750K Direct Offering

summarizeSummary

Nexalin Technology entered a $15 million equity line with Alumni Capital and raised $750,000 in a direct offering, providing capital but adding dilution risk.

check_boxKey Events · Financing and Capital Events · NXL

• $15M Equity Line Established

  Under an Any Market Purchase Agreement with Alumni Capital LP, Nexalin can sell up to $15 million of common stock at a discount to market over the term ending December 31, 2027.

• $750K Direct Offering Priced

  The company sold 2,419,355 shares at $0.31 per share in a registered direct offering, raising approximately $750,000 before expenses, with 1,209,677 warrants exercisable at $0.50 per share.

• Commitment Fee and Advisory Costs

  Nexalin agreed to pay a 2% commitment fee ($300,000) to Alumni Capital, payable in cash or shares, and a $100,000 non-refundable advisory fee to Maxim Group LLC.

• Discount Pricing Mechanics

  Under the equity line, Alumni Capital purchases shares at 92% of the 3-day VWAP or 97% of the prior-day low, providing capital but at a discount to market.

auto_awesomeAnalysis · NXL · Industrial Applications And Services

A $15 million equity line of credit from Alumni Capital LP gives Nexalin Technology the right to sell shares at a discount to market over the next 16 months, providing much-needed capital runway for a company facing a going concern warning and Nasdaq delisting proceedings. The deal also includes a $750,000 direct offering at $0.31 per share with warrants, and a $100,000 advisory fee to Maxim Group. However, the discount pricing and potential dilution are significant for existing shareholders.